Catamaran harnesses the natural cancer-fighting properties of NK cells, the power of synthetic biology and innovative non-viral cell engineering to create novel CAR-NK cell therapies
Total raised: $42M
Founded date: 2020
Investors 3
Date | Name | Website |
24.11.2020 | Sofinnova ... | sofinnovap... |
- | Takeda Ven... | takeda.com |
- | SV Health ... | svhealthin... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
23.11.2020 | Series A | $42M | - | pitchbook.... |
Mentions in press and media 9
Date | Title | Description | Category | Author | Source |
05.04.2022 | Catamaran ... | — Appointment of experienced c... | - | - | svhealthin... |
26.04.2021 | Catamaran ... | CAMBRIDGE, Mass. – April 26, 2... | - | - | svhealthin... |
24.11.2020 | Catamaran ... | Catamaran Bio has raised $42 m... | - | - | pitchbook.... |
24.11.2020 | Catamaran ... | - | - | - | vcbay.news... |
23.11.2020 | Catamaran ... | Catamaran Bio, Inc., a biotech... | - | - | citybizlis... |
23.11.2020 | Catamaran ... | Company brings together scient... | - | - | svhealthin... |
23.11.2020 | Catamaran ... | CAMBRIDGE, MA, Catamaran Bio... | - | - | vcnewsdail... |
23.11.2020 | Catamaran ... | Catamaran Bio, Inc., a Cambrid... | USA | - | finsmes.co... |
23.11.2020 | The Briefi... | 5 Shares Email Facebook Twitte... | Venture | - | news.crunc... |